Maravai LifeSciences Holdings, Inc. (MRVI)

MRVI Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	269.91	322.4	574.96	632.14	551.27	236.18
Trading Asset Securities	-	1.38	-	-	-	-
Cash & Short-Term Investments	269.91	323.77	574.96	632.14	551.27	236.18
Cash Growth	-53.44%	-43.69%	-9.04%	14.67%	133.41%	856.21%
Accounts Receivable	27.88	38.52	54.61	138.62	117.51	51.02
Other Receivables	-	0.7	1.1	8.19	-	-
Receivables	27.88	39.22	55.71	146.81	117.51	51.02
Inventory	46.67	50.08	51.4	43.15	51.56	33.3
Prepaid Expenses	15.31	16.07	17.85	25.8	19.7	11.1
Total Current Assets	359.76	429.15	699.91	847.9	740.04	331.6
Property, Plant & Equipment	162.73	217.03	222.65	116.59	95.43	101.31
Long-Term Investments	-	-	8.56	11.36	0.54	-
Goodwill	129.43	159.88	326.03	283.67	152.77	224.28
Other Intangible Assets	193.07	194.96	220.99	216.66	117.57	177.66
Long-Term Deferred Tax Assets	-	-	-	765.8	808.12	431.7
Long-Term Deferred Charges	1.6	-	-	-	-	3.4
Other Long-Term Assets	50.38	7.24	9.32	40.33	3.82	0.76
Total Assets	896.97	1,008	1,487	2,282	1,918	1,271
Accounts Payable	11.53	11.96	10.73	5.99	8.15	8.17
Accrued Expenses	23.98	28.02	29.04	35.44	28.32	34.38
Current Portion of Long-Term Debt	5.44	5.44	5.44	5.44	6	6
Current Portion of Leases	8.8	8.27	7.41	6.27	3.72	0.79
Current Income Taxes Payable	-	-	-	-	0.1	2.29
Current Unearned Revenue	2.58	3.29	5.52	4.75	12.64	79.15
Other Current Liabilities	17.36	-	29.33	52.25	34.84	-
Total Current Liabilities	69.68	56.97	87.47	110.14	93.78	130.78
Long-Term Debt	288.44	290.49	518.71	522	524.59	528.61
Long-Term Leases	68.4	72.49	79.41	51.56	40.91	56.19
Long-Term Deferred Tax Liabilities	2.03	-	-	-	-	8.61
Other Long-Term Liabilities	0.44	11.09	11.98	693.38	713.64	391.75
Total Liabilities	428.98	431.04	697.57	1,377	1,373	1,116
Common Stock	2.55	2.53	2.51	2.55	2.55	2.58
Additional Paid-In Capital	191.38	181.87	128.5	137.9	128.39	85.13
Retained Earnings	71.36	140.89	285.74	404.77	184.56	0.85
Comprehensive Income & Other	0.57	-	-	-	-	-0.04
Total Common Equity	265.86	325.29	416.75	545.22	315.5	88.51
Minority Interest	202.12	251.92	373.13	360.03	229.86	66.24
Shareholders' Equity	467.98	577.21	789.88	905.24	545.36	154.75
Total Liabilities & Equity	896.97	1,008	1,487	2,282	1,918	1,271
Total Debt	371.08	376.69	610.97	585.26	575.22	591.59
Net Cash (Debt)	-101.17	-52.92	-36.01	46.88	-23.95	-355.41
Net Cash Per Share	-0.71	-0.38	-0.27	0.18	-0.09	-12.29
Filing Date Shares Outstanding	144.68	143.65	132.31	131.79	131.49	96.65
Total Common Shares Outstanding	144.62	141.98	132.23	131.69	131.49	96.65
Working Capital	290.08	372.18	612.44	737.76	646.26	200.82
Book Value Per Share	1.84	2.29	3.15	4.14	2.40	0.92
Tangible Book Value	-56.64	-29.54	-130.26	44.89	45.16	-313.42
Tangible Book Value Per Share	-0.39	-0.21	-0.99	0.34	0.34	-3.24
Land	-	-	-	-	-	0.82
Buildings	-	-	-	-	-	2.13
Machinery	-	73.36	48.79	35.91	31.07	23.16
Construction In Progress	-	23.76	39.64	13.19	6.92	20.38
Leasehold Improvements	-	37.59	24.87	20.1	18.16	1.64

Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q